For decades, the pharmaceutical industry, along with other highly regulated sectors, has grappled with the often-cumbersome process of medical writing. Writers must comply with strict guidelines from regulatory bodies such as the FDA and EMA when creating clinical trial reports and regulatory submissions. Failure to comply can result in delays or rejection. The advent of…